Alison Cecily Finger is Chief Commercial Officer of bluebird bio, Inc.. Currently has a direct ownership of 25,103 shares of BLUE, which is worth approximately $195,552. The most recent transaction as insider was on Jan 06, 2021, when has been sold 1,814 shares (Common Stock) at a price of $45.11 per share, resulting in proceeds of $81,830. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.1K
0% 3M change
0% 12M change
Total Value Held $195,552

ALISON CECILY FINGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2021
SELL
Open market or private sale
$81,830 $45.11 p/Share
1,814 Reduced 6.74%
25,103 Common Stock
Jan 05 2021
SELL
Open market or private sale
$1,798 $44.95 p/Share
40 Reduced 0.15%
26,917 Common Stock
Dec 02 2020
SELL
Open market or private sale
$1,668 $46.34 p/Share
36 Reduced 0.13%
26,957 Common Stock
Nov 02 2020
SELL
Open market or private sale
$1,876 $53.59 p/Share
35 Reduced 0.13%
26,993 Common Stock
Oct 02 2020
SELL
Open market or private sale
$1,900 $52.77 p/Share
36 Reduced 0.13%
27,028 Common Stock

Also insider at

DBTX
Decibel Therapeutics, Inc. Healthcare
ADMA
ADMA BIOLOGICS, INC. Healthcare
ACF

Alison Cecily Finger

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE